CMPS: financial statements from SEC

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Research and development	26M	27M	30M	31M	33M	29M
Selling, general and administrative	16M	13M	13M	19M	15M	14M
Operating expenses	43M	41M	43M	50M	48M	43M
Operating income	−43M	−41M	−43M	−50M	−48M	−43M
Pre-tax income	91M	−138M	−38M	−18M	−38M	−38M
Income tax	−11,000	−230,000	137,000	354,000	173,000	176,000
Net income	91M	−138M	−38M	−18M	−39M	−38M
Earnings per share	0.71	−1.44	−0.41	−0.20	−0.56	−0.56
Earnings per share, diluted	−0.30	−1.44	−0.41	−0.24	−0.56	−0.56
Weighted average shares	110M	95M	93M	89M	68M	68M
Weighted average shares, diluted	130M	95M	93M	99M	68M	68M

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	466M	150M	186M	222M	260M	165M	207M	229M
Current assets	511M	191M	242M	276M	305M	201M	234M	265M
Total assets	532M	210M	256M	294M	319M	214M	247M	279M
Current liabilities	154M	248M	197M	31M	30M	34M	26M	22M
Short-term debt	0	18M	13M	8M	9M	6M	2M	—
Long-term debt	50M	14M	19M	23M	22M	25M	28M	29M
Total liabilities	205M	263M	218M	131M	124M	59M	54M	52M
Equity	327M	−53M	38M	163M	195M	155M	193M	226M
Shares outstanding	135M	96M	96M	94M	93M	69M	68M	68M
Shares issued	135M	96M	96M	94M	93M	69M	68M	68M

Metric	31/03/2026	31/03/2025
Operating cash flow	−48M	−46M
Depreciation and amortisation	0	37,000
Share-based compensation	3M	4M
Financing cash flow	362M	140M